The Emergence of a Multidrug-Resistant and Pathogenic ST42 Lineage of Staphylococcus Haemolyticus from a Hospital in China
Overview
Authors
Affiliations
Staphylococcus haemolyticus is an opportunistic pathogen associated with hospital-acquired infections. However, the genetic diversity of among the patients and the hospital environment is largely unknown. Here, we isolated 311 strains from different sampling sites of patients and hospital environment. Genomic analysis showed that ST42 is an emerging clone widely disseminated in the hospital. ST42 strains exhibited decreased susceptibilities for multiple antibiotics compared with other STs and carried significantly more antibiotic resistance genes (ARGs). Furthermore, ST42 strains harbored more virulence genes per isolate than in other STs, and the capsular biosynthesis genes DEFG were more prevalent in ST42 strains. Using the Galleria mellonella infection model, we demonstrated that ST42 strains are highly virulent compared with non-ST42 strains. Taken together, our data identified an emerging ST42 clone of with aggregated ARGs and virulence determinants in the hospital, representing a significant health threat in terms of both disease and treatment. is an emerging opportunistic pathogen with a high burden of antimicrobial resistance. We performed molecular epidemiological analysis of that was isolated from a hospital, and found that the phylogenetic lineages are diverse accompanied by a dominant epidemic clonal lineage ST42. We demonstrated that ST42 strains have been disseminated among patients and the hospital environment. The data provide mechanistic insight and indicate that ST42 strains are multidrug-resistance and virulent clones via accumulating more ARGs and virulence genes.
Rio-Tinto A, Costa N, Alvim D, Oliveira L, De Oliveira T, Dos Santos K Sci Rep. 2024; 14(1):14961.
PMID: 38942787 PMC: 11213943. DOI: 10.1038/s41598-024-64422-9.
Liu Z, Wang L, Sun J, Zhang Q, Peng Y, Tang S Infect Drug Resist. 2024; 17:1291-1301.
PMID: 38576824 PMC: 10992674. DOI: 10.2147/IDR.S455051.
Dong W, Peng Q, Tang X, Zhong T, Lin S, Zhi Z Infect Drug Resist. 2023; 16:3639-3647.
PMID: 37313263 PMC: 10259589. DOI: 10.2147/IDR.S411860.
Lin L, Chang S, Ou Y, Liu T, Lu J Int J Mol Sci. 2023; 24(7).
PMID: 37047168 PMC: 10094739. DOI: 10.3390/ijms24076198.